Stay updated with breaking news from World Dynamix. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Spherix Global Insights finds doctors have yet to define where APT-1011 will sit in the treatment path relative to EoE treatment gold standard, Dupixent....
Prospects for Syfovre uptake and trust in Apellis take a plunge following reports of intraocular inflammation, according to Spherix Global Insights...
In the third annual patient chart analysis, major treatment shifts in biologic use and average daily steroid dose were observed....
/PRNewswire/ -- Spherix Global Insights recently released data from their Launch Dynamix™: Trudhesa in Acute Treatment of Migraine (US) deep dive study...
/PRNewswire/ -- On February 16, The Lancet Neurology published the Phase 3 results of Pfizer's zavegepant for the acute treatment of migraine. The CGRP...